Back to results
US 2012/0258934 A1Published application
Fosfomycin pharmaceutical composition
OwnerPicornell Darder Carlosinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a solid fosfomycin pharmaceutical composition stable in front the coloration, suitable for diabetics and not entailing gastrointestinal problems. The pharmaceutical composition of this invention comprises fosfomycin trometamol, glycine, and optionally other excipients as sucralose, silice dioxide, polyvinylpyrrolidone and flavour; and is substantially free from sugars and sugar alcohols as sucrose, fructose, glucose, xylitol, mannitol, sorbitol or mixtures thereof.
Claims13
Stable solid fosfomycin pharmaceutical composition for oral administration characterized by comprising
- a) fosfomycin trometamol,
- b) glycine and
- c) optionally other pharmaceutical acceptable excipients,
- and it is substantially free from sugars and sugar alcohols such as sucrose, fructose, glucose, xylitol, mannitol, sorbitol or mixtures thereof.
1 more element
Dependencies are inferred from the claim text.